(Q35850856)

10 August 2017

The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy (English)

1 reference

10 August 2017

Hans Löfgren

1

1 reference

10 August 2017

1 June 2007

1 reference

Australia and New Zealand Health Policy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

10

1 reference

Creative Commons Attribution 2.0 Generic

10 August 2017

start time

1 June 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

India's pharmaceutical industry: hype or high tech take-off?

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1896171

Some drugs more equal than others: pseudo-generics and commercial practice

11 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1896171

The changing structure of the pharmaceutical industry

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17543115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Generic drugs: international trends and policy developments in Australia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17543115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1743-8462-4-10

1 reference

PMC publication ID

1896171

Dimensions Publication ID

10 August 2017

0 references

1 reference

PMC publication ID

1896171

10 August 2017

PubMed publication ID

17543115

1 reference

PMC publication ID

1896171